Hans Bishop - Agilent Technologies Independent Director

A
 Stock
  

USD 122.74  0.98  0.79%   

  Director
Mr. Hans Edgar Bishop serves as Independent Director of the Company. Mr. Bishop served as president, chief executive officer and a member of the Board of Directors of Juno Therapeutics, Inc. from September 2013 to March 2018 when Juno was acquired by Celgene Corporationrationration. From February 2012 until October 2012, Mr. Bishop was the chief operating officer of Photothera Inc., a latestage medical device company owned by Warburg Pincus, and he continued working with Warburg Pincus as an Executive in Residence until October 2013. Prior to joining Photothera Inc., Mr. Bishop served as executive vice president and chief operating officer at Dendreon Corporationrationration, a publiclytraded biopharmaceutical company, from January 2010 to September 2011
Age: 56  Director Since 2017      
800 227 9770  https://www.agilent.com
Bishop has also served as the president of the specialty medicine business at Bayer Healthcare Pharmaceuticals Inc. from December 2006 to January 2010, where he was responsible for a diverse portfolio of neurology, oncology and hematology products.

Agilent Technologies Management Efficiency

Agilent Technologies has return on total asset of 9.08 % which means that for every 100 dollars spent on asset, it generated profit of $9.08. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 25.43 %, implying that it made 25.43 on every $100 invested by shareholders. Agilent Technologies management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 3.07 B in total debt with debt to equity ratio (D/E) of 0.6, which looks OK as compared to the sector. Agilent Technologies has a current ratio of 1.97, which is considered satisfactory as compared to similar companies. Debt can assist Agilent Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Agilent Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Agilent Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Agilent to invest in growth at high rates of return. When we think about Agilent Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 14 records

DIRECTOR Since

William GordonAmazon Inc
2003
John BrownAmazon Inc
2004
Daniel HuttenlocherAmazon Inc
2016
Tom AlbergAmazon Inc
2016
Thomas RyderAmazon Inc
2011
Alain MonieAmazon Inc
2008
Indra NooyiAmazon Inc
2019
Wendell WeeksAmazon Inc
2016
Rosalind BrewerAmazon Inc
2019
Jamie GorelickAmazon Inc
2012
Jonathan RubinsteinAmazon Inc
2010
Patricia StonesiferAmazon Inc
2017
Thomas AlbergAmazon Inc
2011
Judith McGrathAmazon Inc
2014
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 17400 people. Agilent Technologies (A) is traded on New York Stock Exchange in USA and employs 17,400 people.

Agilent Technologies Leadership Team

Elected by the shareholders, the Agilent Technologies' board of directors comprises two types of representatives: Agilent Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agilent. The board's role is to monitor Agilent Technologies' management team and ensure that shareholders' interests are well served. Agilent Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agilent Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Padraig McDonnell, Senior Vice President and Presidentident - Agilent CrossLab Group
Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, Agilent, President - Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, Agilent, President - Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Mikael Dolsten, Independent Director
Allison Ballmer, Vice President - Strategy and Corporate Development
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President, Agilent and President - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Otis Brawley, Independent Director
Dominique Grau, Senior Vice President of Human Resources and Global Communications
Susan Rataj, Independent Director
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Katharine Knobil, Chief Medical Officer.
Boon Koh, Non-Executive Independent Chairman of the Board
Robert Herbold, Independent Director

Agilent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agilent Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Agilent Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Agilent Technologies' short interest history, or implied volatility extrapolated from Agilent Technologies options trading.

Pair Trading with Agilent Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agilent Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Agilent Technologies

+0.67JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
+0.88DISWalt Disney Fiscal Year End 9th of November 2022 PairCorr
The ability to find closely correlated positions to Agilent Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agilent Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agilent Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agilent Technologies to buy it.
The correlation of Agilent Technologies is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agilent Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agilent Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agilent Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Agilent Technologies information on this page should be used as a complementary analysis to other Agilent Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Agilent Stock analysis

When running Agilent Technologies price analysis, check to measure Agilent Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilent Technologies is operating at the current time. Most of Agilent Technologies' value examination focuses on studying past and present price action to predict the probability of Agilent Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agilent Technologies' price. Additionally, you may evaluate how the addition of Agilent Technologies to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is Agilent Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Agilent Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.